William Werbel
Distinguished in Severe Acute Respiratory Syndrome (SARS)

Dr. William Werbel

Infectious Disease
Johns Hopkins Medicine
Johns Hopkins Bayview Medical Center
Baltimore, MD 

Distinguished in Severe Acute Respiratory Syndrome (SARS)
Johns Hopkins Medicine
Johns Hopkins Bayview Medical Center
Baltimore, MD 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Dr. Werbel is a physician-scientist who provides consultative care for patients at Johns Hopkins who experience infectious disease complications before and after organ transplant, as well as in the setting of solid tumors or blood cancers. His research with the Johns Hopkins Transplant Research Center uses a combination of epidemiological and laboratory methods to better personalize the prevention of infectious complications among patients with complex immunodeficiencies. This includes using national cohort studies and clinical trials to optimize the use of vaccines and other prophylactic therapies for high-risk immunosuppressed populations.

Dr. Werbel is rated as a Distinguished provider by MediFind in the treatment of Severe Acute Respiratory Syndrome (SARS). His top areas of expertise are COVID-19, Severe Acute Respiratory Syndrome (SARS), HIV/AIDS, and Hepatitis.

His clinical research consists of co-authoring 126 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 87 articles and participated in 2 clinical trials in the study of Severe Acute Respiratory Syndrome (SARS).

Residency
McGaw Medical Center of Northwestern University, Internal Medicine, 2016
Specialties
Infectious Disease
Licenses
Internal Medicine in MA
Board Certifications
American Board Of Internal Medicine
Fellowships
Johns Hopkins University School of Medicine, Infectious Diseases, 2020
Hospital Affiliations
The Johns Hopkins Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
First Health
  • INSURANCE PLAN
  • MEDICARE PDP
  • PPO
Geisinger
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
View 1 Less Insurance Carrier -

Locations

Johns Hopkins Bayview Medical Center
Baltimore, MD 21224
Call: 410-550-0100
Other Locations
The Johns Hopkins Hospital
1800 Orleans Street, Baltimore, MD 21287
Call: 410-955-5000

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


2 Clinical Trials

A Randomized Study to Evaluate Antibody Response to an Additional Dose of SARS-CoV-2 Vaccination With and Without Immunosuppression Reduction in Kidney and Liver Transplant Recipients
A Randomized Study to Evaluate Antibody Response to an Additional Dose of SARS-CoV-2 Vaccination With and Without Immunosuppression Reduction in Kidney and Liver Transplant Recipients
Enrollment Status: Completed
Publish Date: January 07, 2026
Intervention Type: Drug, Biological
Study Phase: Phase 2
Immunogenicity of a Third Dose of Either the Moderna COVID-19 Vaccine or Pfizer-BioNTech COVID-19 Vaccine in Kidney Transplant Recipients Who Failed to Respond After Two Previous Doses
Immunogenicity of a Third Dose of Either the Moderna COVID-19 Vaccine or Pfizer-BioNTech COVID-19 Vaccine in Kidney Transplant Recipients Who Failed to Respond After Two Previous Doses
Enrollment Status: Completed
Publish Date: July 30, 2025
Intervention Type: Biological
Study Drugs: mRNA-1273 Vaccine (Pfizer/BioNTech), mRNA-1273 Vaccine (Moderna)
Study Phase: Phase 2
View 1 Less Clinical Trial

125 Total Publications

Trends over Time in Practice and Outcomes of Lung Transplantation in Recipients With Human Immunodeficiency Virus.
Trends over Time in Practice and Outcomes of Lung Transplantation in Recipients With Human Immunodeficiency Virus.
Journal: Transplant infectious disease : an official journal of the Transplantation Society
Published: August 08, 2025
View All 125 Publications
Similar Doctors
Robin K. Avery
Distinguished in Severe Acute Respiratory Syndrome (SARS)
Dr. Robin K. Avery
Infectious Disease
Distinguished in Severe Acute Respiratory Syndrome (SARS)
Dr. Robin K. Avery
Infectious Disease

Johns Hopkins Health Care & Surgery Center - Green Spring Station, Lutherville

10751 Falls Road, Falls Concourse STE 412, Falls Concourse STE 412, 
Lutherville, MD 
 (6.3 miles away)
410-583-2900
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Dr. Robin Avery is an infectious disease physician who joined the Johns Hopkins faculty in 2012, with two decades of experience in transplant infectious disease. She is a past chair of the American Society of Transplantation (AST) Infectious Disease Community of Practice, was a co-editor of the first edition of the AST ID Guidelines, and serves on a Guidelines Committee for the Infectious Disease Society of America (IDSA) on immunizations in the immunocompromised host. She was the founding head of the Transplant Infectious Disease Section at the Cleveland Clinic and served as the founding director of the Cleveland Clinic Transplant ID Special Fellowship, authoring a curriculum that served as the basis for curricula later endorsed by the AST and IDSA. Her clinical and research interests include pre-transplant donor and recipient evaluation, and prevention and treatment of post-transplant infections, particularly transplant-associated viruses, viral load monitoring, novel therapies for CMV, hypogammaglobulinemia, immunizations, and strategies for safer living post-transplant. She has a strong interest in patient education and co-authored the script for a video designed to educate patients on decreasing post-transplant infection risks. Dr. Avery is rated as a Distinguished provider by MediFind in the treatment of Severe Acute Respiratory Syndrome (SARS). Her top areas of expertise are Cytomegalic Inclusion Disease, Cytomegalovirus Infection, COVID-19, and Sepsis.

Kathleen M. Neuzil
Distinguished in Severe Acute Respiratory Syndrome (SARS)
Dr. Kathleen M. Neuzil
Infectious Disease
Distinguished in Severe Acute Respiratory Syndrome (SARS)
Dr. Kathleen M. Neuzil
Infectious Disease
685 W Baltimore St, Room 480, 
Baltimore, MD 
 (5.2 miles away)
410-706-6554
Languages Spoken:
English

Kathleen Neuzil is an Infectious Disease provider in Baltimore, Maryland. Dr. Neuzil is rated as a Distinguished provider by MediFind in the treatment of Severe Acute Respiratory Syndrome (SARS). Her top areas of expertise are Typhoid Fever, Salmonella Enterocolitis, Flu, and COVID-19.

Yuka Manabe
Distinguished in Severe Acute Respiratory Syndrome (SARS)
Dr. Yuka Manabe
Infectious Disease
Distinguished in Severe Acute Respiratory Syndrome (SARS)
Dr. Yuka Manabe
Infectious Disease

The Johns Hopkins Hospital

1800 Orleans Street, 
Baltimore, MD 
 (4.3 miles away)
410-955-5000
Languages Spoken:
English
See accepted insurances

Dr. Yukari Manabe is a Professor in the Division of Infectious Diseases in the Department of Medicine with secondary appointments in the Bloomberg School of Public Health Department of International Health and the Department of Microbiology and Molecular Immunology. Dr. Manabe began her career working on the basic science aspects of tuberculosis (TB) immunopathogenesis in comparative animal models of infection, particularly latency, reactivation, and immune reconstitution inflammatory syndrome (IRIS) in the rabbit model within the Johns Hopkins Center for Tuberculosis Research. In 2007, she was seconded to the Infectious Diseases Institute (IDI) at Makerere College of Health Sciences as the Associate Medical Laboratory Director of the College of American Pathologists certified Makerere University-Johns Hopkins University Clinical Core Lab to study antiretroviral associated TB and IRIS. She then became the Head of Research at the IDI in 2008 until 2012 where she built research capacity and infrastructure to train Ugandan investigators. Since returning to Hopkins, she has become the PI of the Johns Hopkins POC STD Center (U54 funded through NIH) which is part of the newly formed Johns Hopkins Center for Innovative Diagnostics for Infectious Diseases. The Center develops new diagnostics, funds development for point-of-care diagnostics, evaluates (validation and verification) new technology, and performs pre-clinical studies to accelerate the development of infectious disease assays (STIs, TB, acute febrile illness, HIV, syphilis, viral hepatitis). Dr. Manabe is particularly interested in rapid, point-of-care infectious disease diagnostics suitable for the resource-limited settings particularly in sub-Saharan Africa (SSA). Her research has focused on accuracy testing of various rapid, point-of-care diagnostics for HIV and related infectious diseases of clinical importance in SSA. Studies have ranged from evaluations of performance accuracy through clinical implementation science studies on the patient-centered outcomes and impactful use of new rapid diagnostics. Dr. Manabe obtained her undergraduate degree from Yale University and her M.D. from Columbia University College of Physicians and Surgeons. After completing both her residency in Internal Medicine and fellowship in Infectious Diseases at Johns Hopkins Hospital, she joined the faculty in 1999. Dr. Manabe is rated as a Distinguished provider by MediFind in the treatment of Severe Acute Respiratory Syndrome (SARS). Her top areas of expertise are HIV/AIDS, Cryptococcosis, Gonorrhea, Meningitis, and Tissue Biopsy.

VIEW MORE SEVERE ACUTE RESPIRATORY SYNDROME (SARS) DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Werbel's expertise for a condition
ConditionClose
    • Distinguished
    • COVID-19
      Dr. Werbel is
      Distinguished
      . Learn about COVID-19.
      See more COVID-19 experts
    • Severe Acute Respiratory Syndrome (SARS)
      Dr. Werbel is
      Distinguished
      . Learn about Severe Acute Respiratory Syndrome (SARS).
      See more Severe Acute Respiratory Syndrome (SARS) experts
    • Advanced
    • HIV/AIDS
      Dr. Werbel is
      Advanced
      . Learn about HIV/AIDS.
      See more HIV/AIDS experts
    • Experienced
    • Cytomegalic Inclusion Disease
      Dr. Werbel is
      Experienced
      . Learn about Cytomegalic Inclusion Disease.
      See more Cytomegalic Inclusion Disease experts
    • Cytomegalovirus Infection
      Dr. Werbel is
      Experienced
      . Learn about Cytomegalovirus Infection.
      See more Cytomegalovirus Infection experts
    • Hepatitis
      Dr. Werbel is
      Experienced
      . Learn about Hepatitis.
      See more Hepatitis experts
    • Hepatitis C
      Dr. Werbel is
      Experienced
      . Learn about Hepatitis C.
      See more Hepatitis C experts
    • Kaposi Sarcoma
      Dr. Werbel is
      Experienced
      . Learn about Kaposi Sarcoma.
      See more Kaposi Sarcoma experts
    • Pneumocystis Jiroveci Pneumonia
      Dr. Werbel is
      Experienced
      . Learn about Pneumocystis Jiroveci Pneumonia.
      See more Pneumocystis Jiroveci Pneumonia experts
    View All 7 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2026 All Rights Reserved

      Request an Appointment

      If you are experiencing a medical emergency, call 9-1-1.

      MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

      Patient Details

      This information is for the patient who will be seen at the appointment.

        Close

        Returning patient? Use your address on file with the provider.

        Insurance Details

        Please provide information of the primary insurance holder as the practice may require this information to schedule.

        Insurance Provider *
        Insurance ProviderClose

        Appointments Details

        Let’s get more information about your appointment.

                0 / 1000
                0 / 1000
                By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.